Literature DB >> 16997927

Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.

Pamela M McMahon1, Alan M Zaslavsky, Milton C Weinstein, Karen M Kuntz, Jane C Weeks, G Scott Gazelle.   

Abstract

PURPOSE: The authors propose a Bayesian approach for estimating competing risks for inputs to disease simulation models. This approach is suggested when modeling a disease that causes a large proportion of all-cause mortality, particularly when mortality from the disease of interest and other-cause mortality are both affected by the same risk factor.
METHODS: The authors demonstrate a Bayesian evidence synthesis by estimating other-cause mortality, stratified by smoking status, for use in a simulation model of lung cancer. National (US) survey data linked to death registries (National Health Interview Survey [NHIS]--Multiple Cause of Death files) were used to fit cause-specific hazard models for 3 causes of death (lung cancer, heart disease, and all other causes), controlling for age, sex, race, and smoking status. Synthesis of NHIS data with national vital statistics data on numbers and causes of deaths was performed in WinBUGS (version 1.4.1, MRC Biostatistics Unit, UK). Correction for inconsistencies between the NHIS and vital statistics data is described. A published cohort study was a source of prior information for smoking-related mortality.
RESULTS: Marginal posterior densities of annual mortality rates for lung cancer and other-cause death (further divided into heart disease and all other causes), stratified by 5-year age interval, race (white and black), gender, and smoking status (current, former, never), were estimated, specific to a time period (1987-1995). Overall, black current smokers experienced the highest mortality rates.
CONCLUSIONS: Bayesian evidence synthesis is an effective method for estimation of cause-specific mortality rates, stratified by demographic factors.

Entities:  

Mesh:

Year:  2006        PMID: 16997927     DOI: 10.1177/0272989X06291326

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  7 in total

1.  Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.

Authors:  Rebecca A Miksad; Mithat Gönen; Thomas J Lynch; Thomas G Roberts
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

2.  Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.

Authors:  Pamela M McMahon; Chung Yin Kong; Bruce E Johnson; Milton C Weinstein; Jane C Weeks; Karen M Kuntz; Jo-Anne O Shepard; Stephen J Swensen; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

3.  Calibration of disease simulation model using an engineering approach.

Authors:  Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Value Health       Date:  2009-01-12       Impact factor: 5.725

4.  Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.

Authors:  Pamela M McMahon; Chung Yin Kong; Milton C Weinstein; Angela C Tramontano; Lauren E Cipriano; Bruce E Johnson; Jane C Weeks; G Scott Gazelle
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

5.  Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death.

Authors:  Marjorie A Rosenberg; Eric J Feuer; Binbing Yu; Jiafeng Sun; S Jane Henley; Thomas G Shanks; Christy M Anderson; Pamela M McMahon; Michael J Thun; David M Burns
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

6.  Derivation of background mortality by smoking and obesity in cancer simulation models.

Authors:  Y Claire Wang; Barry I Graubard; Marjorie A Rosenberg; Karen M Kuntz; Ann G Zauber; Lisa Kahle; Clyde B Schechter; Eric J Feuer
Journal:  Med Decis Making       Date:  2012-11-06       Impact factor: 2.583

7.  Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Natasha K Stout; Jesse Ortendahl; Karen M Kuntz; Sue J Goldie; Joshua A Salomon
Journal:  Popul Health Metr       Date:  2007-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.